Unknown

Dataset Information

0

Identification of the RP11-21C4.1/SVEP1 gene pair associated with FAT2 mutations as a potential biomarker in gastric cancer.


ABSTRACT: Gastric cancer (GC) is one of the most common malignancies worldwide. Despite rapid advances in systemic therapy, GC remains the third leading cause of cancer-related deaths. We aimed to identify a novel prognostic signature associated with FAT2 mutations in GC. We analyzed the expression levels of FAT2-mutant and FAT2-wildtype GC samples obtained from The Cancer Genome Atlas (TCGA). The Kaplan-Meier survival curve showed that patients with FAT2 mutations showed better prognosis than those without the mutation. Sixteen long non-coding RNAs (lncRNAs) and 62 messenger RNAs (mRNAs) associated with FAT2 mutations were correlated with the prognosis of GC. We then constructed a 4-mRNA signature and a 5-lncRNA signature for GC. Finally, we identified the most relevant RP11-21 C4.1/SVEP1 gene pair as a prognostic signature of GC that exhibited superior predictive performance in comparison with the 4-mRNA or 5-lncRNA signature by weighted gene correlation network analysis (WGCNA) and Cox proportional hazards regression analysis. In this study, we constructed a prognostic signature of GC by integrative genomics analysis, which also provided insights into the molecular mechanisms linked to FAT2 mutations in GC.

SUBMITTER: Zhou L 

PROVIDER: S-EPMC8806586 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of the RP11-21C4.1/SVEP1 gene pair associated with FAT2 mutations as a potential biomarker in gastric cancer.

Zhou Lingshan L   Yang Yuan Y   Liu Min M   Gan Yuling Y   Liu Rong R   Ren Man M   Zheng Ya Y   Wang Yuping Y   Zhou Yongning Y  

Bioengineered 20211201 1


Gastric cancer (GC) is one of the most common malignancies worldwide. Despite rapid advances in systemic therapy, GC remains the third leading cause of cancer-related deaths. We aimed to identify a novel prognostic signature associated with FAT2 mutations in GC. We analyzed the expression levels of FAT2-mutant and FAT2-wildtype GC samples obtained from The Cancer Genome Atlas (TCGA). The Kaplan-Meier survival curve showed that patients with FAT2 mutations showed better prognosis than those witho  ...[more]

Similar Datasets

| S-EPMC11905629 | biostudies-literature
| S-EPMC6818562 | biostudies-literature
| S-EPMC4058523 | biostudies-literature
| S-EPMC9110618 | biostudies-literature
| S-EPMC6020231 | biostudies-literature
| S-EPMC10394090 | biostudies-literature
| S-EPMC9100412 | biostudies-literature
| S-EPMC9329618 | biostudies-literature
| S-EPMC11779956 | biostudies-literature
| S-EPMC7666586 | biostudies-literature